Conference Coverage

Patients with intellectual disability require nuanced care


 

REPORTING FROM APA 2019

– Some physicians are uncomfortable providing mental health care to patients with intellectual disability (ID) because many of the patients’ communications skills are limited. But many resources are available that can help.

In this video, Nita V. Bhatt, MD, MPH, interviews Julie P. Gentile, MD, about some of those resources and discusses how to approach psychiatric treatment interventions for patients with ID.

In addition to the DSM-5, Dr. Gentile said the National Association for the Dually Diagnosed has published the Diagnostic Manual – Intellectual Disability. Another resource is a practical reference manual originally proposed by one of Dr. Gentile’s residents.

“He came into my office for supervision one day and said, ‘You know, there’s all these nuances for psychiatric treatment in this patient population. So we should write a practice, quick reference manual to help clinicians who aren’t able to spend as much time concentrate on this patient population.’ ”

As a result, several residents and faculty members formed a team to produce an 18-chapter book published this year by Springer called the Guide to Intellectual Disabilities: A Clinical Handbook.

Dr. Bhatt is a staff psychiatrist at Twin Valley Behavioral Healthcare, the state psychiatric hospital in Columbus, Ohio. Dr. Gentile is professor and chair of the department of psychiatry at Wright State in Dayton. She is also serves as project director of Ohio’s Telepsychiatry Project for Intellectual Disability and has been awarded more than $7 million in grant funding to support her projects in the field of ID.

Dr. Gentile’s work has been funded by the Ohio Department of Developmental Disabilities and the Ohio Department of Mental Health and Addiction Services.

Recommended Reading

Total plasma tau correlates with dementia onset, Alzheimer’s disease
MDedge Psychiatry
Boosting Alzheimer’s trial participation via Medicare Advantage ‘memory fitness programs’
MDedge Psychiatry
Alzheimer’s update: George Grossberg
MDedge Psychiatry
Biogen, Eisai discontinue aducanumab Alzheimer’s trials
MDedge Psychiatry
Amyloid brain imaging changed clinical management in 60% of MCI and dementia patients
MDedge Psychiatry
BACE-1 inhibition worsens cognition in patients with prodromal Alzheimer’s disease
MDedge Psychiatry
Plasma levels of neurofilament light track neurodegeneration in MCI and Alzheimer’s disease
MDedge Psychiatry
AD biomarker not tied to increased interest in physician-assisted death
MDedge Psychiatry
Experts propose new definition and recommendations for Alzheimer’s-like disorder
MDedge Psychiatry
Report on newly recognized cause of dementia should be read widely
MDedge Psychiatry